Kumaravel Vivek

Title: The Innovative Journey of Kumaravel Vivek

Introduction

Kumaravel Vivek, an accomplished inventor based in Chennai, India, is known for his significant contributions to the pharmaceutical industry. With a focus on improving drug delivery systems, he has been instrumental in developing innovative formulations that enhance therapeutic efficacy and patient compliance.

Latest Patents

Kumaravel has secured two notable patents in his field. His first patent is for a "Pharmaceutical gastro-retentive solid oral dosage form of nilotinib," which encompasses a method for creating a dosage form containing nilotinib as the active ingredient. This invention aims to improve the bioavailability of the drug by ensuring prolonged retention in the gastrointestinal tract.

The second patent, "Multilayered dosage form," involves the design of a multilayered coated tablet consisting of three distinct layers, where the first and third layers contain an active pharmaceutical ingredient, while the second layer may be a placebo or an immediate-release drug. This innovative tablet features a delayed-release coating designed with pore-forming agents, allowing for controlled drug release, thus enhancing patient adherence to treatment regimens.

Career Highlights

Kumaravel currently works at Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His expertise in pharmaceutical formulation development has made him a crucial asset to the team, contributing to the advancement of innovative drug delivery solutions.

Collaborations

Throughout his career, Kumaravel has collaborated with talented individuals such as Romi Barat Singh and Anuj Kumar Fanda. These partnerships have fostered an environment of creativity and innovation, leading to the successful development of groundbreaking pharmaceutical products.

Conclusion

Kumaravel Vivek's dedication to innovation in the pharmaceutical sector has resulted in significant advancements in drug formulations, focusing on improving patient outcomes. His patents reflect a commitment to enhancing drug efficacy and safety. As he continues his work at Sun Pharmaceutical Industries Limited, Kumaravel remains a notable figure in the world of pharmaceutical inventions.